PR Special Fasig-Tipton November: Whose Stock Is Rising In The Stallion Market?

CLICK HERE TO READ THIS EDITION OF THE PR SPECIAL

The major mixed auction kicks off a big couple of weeks starting with the Sunday's Fasig-Tipton November Sale, and the Paulick Report has the reading material you need for the day in the PR Special.

This issue – featuring exclusive content not yet seen on the website – sees bloodstock editor Joe Nevills examining the recently released Jockey Club Report of Mares Bred to see which stallions made the biggest year-to-year jumps in the number of mares they covered in 2020.

The Stallion Spotlight shines on Shadwell Farm's Qurbaan, a multiple Grade 2-winning son of Speightstown who completed his first season at stud in 2020. In this issue's installment of INQUIRY, we ask folks on the sales grounds about their favorite music to listen to on the road, and get a wide range of results.

Dr. Charlie Scoggin of Rood and Riddle Equine Hospital discusses the cap on stud book size for colts born in 2020 or later from his professional perspective in Ask Your Veterinarian. Then, Bryce Burton of Muirfield Insurance explains how your equine insurance plan interacts with equine loans in Ask Your Insurer. Finally, Nevills takes a dive through the Fasig-Tipton November catalog to focus on the rookie stallions in First Crop Sire Watch.

CLICK HERE TO READ THIS EDITION OF THE PR SPECIAL

Thanks, as always, to our advertisers in this issue of the PR Special. Your support is crucial to the functioning of the Paulick Report.

CLICK HERE TO READ THIS EDITION OF THE PR SPECIAL

The post PR Special Fasig-Tipton November: Whose Stock Is Rising In The Stallion Market? appeared first on Horse Racing News | Paulick Report.

Source of original post

Ask Your Veterinarian Presented By Kentucky Performance Products: What We Know About This Year’s Placentitis Cases

Veterinarians at Rood and Riddle Equine Hospital answer your questions about sales and healthcare of Thoroughbred auction yearlings, weanlings, 2-year-olds and breeding stock. If you have a question for a veterinarian, email us info at paulickreport.com .

QUESTION: We saw an increased number of nocardioform placentitis in the 2020 foaling season. Why are some years worse for placentitis than others?

DR. MARIA SCHNOBRICH: In the 2020 foaling season in Central Kentucky saw an increase in the incidence of Nocardioform placentitis. The University of Kentucky Veterinary Diagnostic Laboratory reported that this was the second worst year for Nocardioform placentitis behind 2011, when they had 328 confirmed cases. In 2020 there were 207 cases confirmed. Likely these numbers represent an underrepresentation, as not all cases are submitted for evaluation.

Nocardioform placentitis is a type of placentitis that is associated with isolation of a slow-growing, gram-positive family of bacteria that are found in the placenta after delivery or abortion. These bacteria (Crosiella, Amycolytopsis, Actinomycetes) are thought to originate from the soil, but frustratingly we do not know at this time how the disease process starts or what is the reason it develops in some mares and not others. This type of placentitis usually causes well-demarcated lesions in the placenta where a mucoid plaque develops and causes the placenta to be disrupted, and may limit or severely compromise fetal development. The outcome of mares affected with this type of placentitis can range from abortion to normal foals and does not always correlate to the severity of the lesions.

Due to the increased incidence of this disease last year, many involved with the broodmare management, including veterinarians, farm managers, owners and researchers worked together to collect and compare data. The UK Gluck Equine Research Center's Dr. Barry Ball is currently compiling data from this past year and will be making his team's findings available to the public.

Dr. Maria Schnobrich

Frustratingly, despite many attempts to reproduce the disease, we do not know what causes or initiates Nocardioform placentitis in the mare. While researchers continue to work on this, we have learned several things which I will summarize below.

  • The incidence of Nocardioform placentitis seems to be associated with weather. When conditions are hot and dry (as they were in the late summer and early fall of 2019), there is an increase in disease. When conditions are wet and cold, we see a decrease in this type of placentitis, while other diseases like leptospirosis may increase.

    Evaluations of soil samples from 2019 are pending and may help give us insight on whether this bacteria was more common. Previously the bacteria found in affected placentas could not be found in the soil from the affected farms when the soil was cultured much later in the year. The new data from 2019-20, when the soil was cultured closer to the time of possible infection, may be helpful in identifying why we had an increase.

  • Nocardioform placentitis does not occur only in Kentucky, as might have been previously thought. There are cases reported and diagnosed in animals that have never been in Kentucky, though we in Kentucky at the moment seem to have the highest incidence.
  • Natural cover is not required to produce the disease. Confirmed cases of Nocardioform placentitis occurred in mares bred by artificial insemination and even embryo transfer recipients.
  • Screening for the disease remains problematic as we have no sure way of identifying the issue. Diagnostic tools that may aid the owner and veterinarian in identifying affected patients include:
  1. Clinical signs such as premature udder development, and rarely vulvar discharge.
  2. Transabdominal and transrectal ultrasound which may identify lesions before they become advanced. The downside of ultrasound in the pregnant mare is that the entire placenta can't be visualized, so some cases may be missed. The advantage is this may allow you to identify an issue earlier in the course of the disease and implement treatment then.
  3. Evaluation of hormones to assess pregnancy (estrogens and progesterone). Screening may result in identifying cases with significant pathology or compromise. In cases that were presented to a referral clinic, all animals had abnormalities in these values, though this needs further research to determine how useful a screening tool it may be.

This image shows the ultrasound image generated from a transabdominal screen of a pregnant mare. The blue arrow is pointing to an area where the uterus has separated from the fetal membranes and placental disruption is caused by a dense fluid. This area correlates to our findings of thick mucoid debris caused in areas affected by Nocardioform placentitis.

  • There seems to be little resistance to commonly used antibiotics when isolates from the disease were tested for susceptibility in vitro. Doxycycline (81-96% sensitivity) and TMS/SMZ (80%-95%) were incredibly effective when isolates from 2020 placentitis cases were tested in the lab.
  • The data regarding which treatment for this type of placentitis is most effective is confusing. Research by Gluck's Dr. Carleigh Fedorka demonstrated that cases that were treated actually had a worse outcome than untreated cases. Additionally, the only treatment which seemed to have a positive effect on pregnancy outcome was Firocoxib (Equioxx), an anti-inflammatory. We have to remember though that this data reflects animals that were treated because they were identified as having an issue, and so likely had more severe disease than those untreated animals. There are few situations in which an animal identified with disease would have been left untreated, as this usually results in a poor outcome.

This picture shows the brown discoloration caused from Nocardioform placentitis that can be found on the fetal membranes after delivery. Often there is thick, viscous debris that has been described as similar to “peanut butter” in consistency.

In summary, Nocardioform placentitis continues to be a sporadic but significant issue for the Thoroughbred industry. While it may affect us worse in certain years it has highlighted our need for vigilant monitoring of the pregnant mare and a continued effort to identify early markers of pregnancy compromise. As we now have seen trends related to weather this may give us an idea as to which years will be worse, but discussion with your veterinarian and farm manager about screening and treatment is recommended as it is a complicated issue without a clear recipe for management.

Dr. Maria Schnobrich grew up in Boston where visits to her grandparents' farm and riding lessons at a young age sparked her interest in horses and large animals. Dr. Schnobrich graduated Magna Cum Laude at Brown University followed by attending veterinary school at the University of Pennsylvania. She is a Diplomate of the American College of Theriogenology.

The post Ask Your Veterinarian Presented By Kentucky Performance Products: What We Know About This Year’s Placentitis Cases appeared first on Horse Racing News | Paulick Report.

Source of original post

PR Special Fasig-Tipton October: How Do They Set Those Stud Fees?

CLICK HERE TO READ THIS EDITION OF THE PR SPECIAL

The Fasig-Tipton Kentucky October Yearlings Sale rolls on, and the Paulick Report has the reading material you need to go along with it in the latest PR Special.

In this edition, bloodstock editor Joe Nevills speaks to the decision-makers at some of Kentucky's top stallion operations about their processes for setting stud fees – a number that can have ramifications on a stallion's entire career.

Darley's Australian shuttle stallion Astern is the focus of this issue's Stallion Spotlight, with Darren Fox discussing what makes the son of Medaglia d'Oro an attractive prospect for breeders. In the Breeders' Cup Buzz, Nevills asks participants in the upcoming Breeders' Cup to recall their most vivid memories of the 2015 renewal, the last time the event was at Keeneland.

Dr. Maria Schnobrich of Rood and Riddle Equine Hospital covers why some years are worse than others for placentitis in Ask Your Veterinarian, and finally, we dive through the Fasig-Tipton October catalog to spotlight some of its young stallions in Second-Crop Sire Watch.

CLICK HERE TO READ THIS EDITION OF THE PR SPECIAL

Thanks, as always, to the sponsors of the PR Special. Your continued support is crucial to the functioning of our publication.

CLICK HERE TO READ THIS EDITION OF THE PR SPECIAL

The post PR Special Fasig-Tipton October: How Do They Set Those Stud Fees? appeared first on Horse Racing News | Paulick Report.

Source of original post

Ask Your Veterinarian Presented By Kentucky Performance Products: Pre-Sale Medication Regs ‘A Good Change’

Veterinarians at Rood and Riddle Equine Hospital answer your questions about sales and healthcare of Thoroughbred auction yearlings, weanlings, 2-year-olds and breeding stock. If you have a question for a veterinarian, email us info at paulickreport.com

QUESTION: What is the veterinary perspective on the new pre-sale medication restrictions in force at public auctions in the United States?

DR. BART BARBER: From this veterinarian's perspective, the changes that the sales companies have made are positive. The limitations that have been imposed add a degree of confidence to buyers while still allowing sellers and veterinarians to fully treat horses as needed with only a few exceptions.

Dr. Bart Barber

There are some subtle differences but the changes for both sales companies are very similar. One of the new rules that each have applied is that only one non-steroidal anti-inflammatory drug (NSAID) and one corticosteroid may be used. There can be no stacking of drugs within the classes. There are lots of drugs in each of these categories and they have similar actions and effects within each class. That said, there are differences that make drugs in each of those classes superior for treating specific conditions. For instance, one NSAID is preferred to treat pain associated with colic while another is preferred for musculoskeletal pain. Certain steroids are better suited for treating allergic reactions while others are best at treating head trauma. The point is that there are reasons why one NSAID or corticosteroid is chosen over another and why there are several different choices.

In the rare case that a horse has already been treated with one of these medications for a specific condition and another condition arises for which another medication in the same class is needed, decisions will need to be made. First and foremost the horse will be taken care of. It is important to point out that this situation would not automatically disqualify the horse from being sold. A positive test for multiple NSAIDs or corticosteroids merely gives the buyer the right to rescind the sale. The goal of the new regulations is not to limit treating horses appropriately but to limit indiscriminate stacking of NSAIDs and corticosteroids, which is in the best interest of the buyers, the sales process, the industry and, ultimately, the horse. It's a good change. When the situation described above arises, it will be in the best interest of all parties to come together, use good judgment and horsemanship to determine intent, the best interests of the horse, and whether or not the process was compromised. These occasions will likely be rare and I believe that even in these instances we will be able to care for the horses without compromising the intent of the rules.

Bronchodilators, including clenbuterol, have been limited in that they have been completely banned for a time period prior to the sale. There is a potential for abuse of these medications and again this is a positive change to protect the horse. When this change was announced some chose to not use this class of medications in horses at any age, for any condition and I believe that is a mistake. Taking this out of a veterinarian's toolbox for use in foals could have fatal consequences. There are legitimate uses for these medications and they should be used when they are warranted. The sales companies have not limited their use when appropriate for age and condition, they have merely asked for disclosure.

The balancing of allowing for appropriate use and imposing rules to curtail abuse is difficult. In this case it has been well thought out and will benefit all involved.

Dr. Bart Barber, DVM, is a shareholder in Rood and Riddle's veterinary practice and specializes in reproduction, primary and preventative ambulatory care, as well as operations at Rood and Riddle Veterinary Pharmacy.

The post Ask Your Veterinarian Presented By Kentucky Performance Products: Pre-Sale Medication Regs ‘A Good Change’ appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights